Literature DB >> 15108256

Bone mineral density among cirrhotic patients awaiting liver transplantation.

Rana Paramvir Sokhi1, Abhinandana Anantharaju, Ravi Kondaveeti, Steven D Creech, Khondker K Islam, David H Van Thiel.   

Abstract

Osteoporosis is an important and common complication in patients with chronic liver disease. The goal of this study was to determine the bone mineral density (BMD) in different subgroups among pretransplant cirrhotic patients. BMD of the lumbar vertebrae (L) and femoral neck (F) were obtained in 104 consecutive cirrhotic patients. Descriptive and inferential statistics were used to compare the BMD among various groups. The mean BMD in males (n = 54) and females (n = 50) at L were 1.28 +/- 0.25 g/cm(2) and 1.13 +/- 0.20 g/cm(2), respectively (P =.001); at F they were 1.03 +/- 0.14 and 0.91 +/- 0.17, respectively (P <.0001). Among males, BMD at L in Child-Turcotte-Pugh class B and C were 1.40 +/- 0.21 and 1.13 +/- 0.20, respectively (P =.001); at F they were 1.11 +/- 0.10 and 0.93 +/- 0.13, respectively (P <.0001). Among females, BMD at L in Child-Turcotte-Pugh class B and C were 1.27 +/- 0.18 and 1.05 +/- 0.16, respectively (P =.0003); at F they were 1.02 +/- 0.16 and 0.83 +/- 0.12, respectively (P =.001). The BMD in premenopausal females (n = 15) and postmenopausal females (n = 35) at L were 1.20 +/- 0.19 and 1.11 +/- 0.20, respectively (P =.15); at F they were 0.97 +/- 0.17 and 0.88 +/- 0.16, respectively (P =.12). The BMD in postmenopausal females on hormone replacement therapy (n = 19) and on no hormone replacement therapy (n = 16) at L were 1.07 +/- 0.17 and 1.14 +/- 0.23, respectively (P =.29); at F they were 0.85 +/- 0.15 and 0.91 +/- 0.18, respectively (P =.33). The BMD values between etiologic groups were not significantly different. The overall prevalence of osteopenia and osteoporosis were 34.6% and 11.5%, respectively, being significantly higher in females than in males. In conclusion, significant difference in BMD values exists between males and females, as well as between Child-Turcotte-Pugh class B and C patients with cirrhosis. In addition, there is no significant influence of menopausal status, hormone replacement therapy, and etiology of cirrhosis on BMD.

Entities:  

Mesh:

Year:  2004        PMID: 15108256     DOI: 10.1002/lt.20104

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  24 in total

1.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

2.  Bone mineralization in children with Wilson's disease.

Authors:  Ahmet Cetinkaya; Hasan Ozen; Aysel Yüce; Inci Nur Saltık-Temizel; Hülya Demir; Figen Gürakan
Journal:  Indian J Gastroenterol       Date:  2014-05-25

Review 3.  Bone health and vitamin D status in alcoholic liver disease.

Authors:  M Kizilgul; O Ozcelik; T Delibasi
Journal:  Indian J Gastroenterol       Date:  2016-06-01

4.  Bone mineral density in children with cirrhosis.

Authors:  Nuray Uslu; Inci Nur Saltik-Temizel; Hülya Demir; Yusuf Usta; Hasan Ozen; Figen Gürakan; Aysel Yüce; Nurten Koçak
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

5.  Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.

Authors:  Germán López-Larramona; Alfredo J Lucendo; Sonia González-Castillo; José M Tenias
Journal:  World J Hepatol       Date:  2011-12-27

Review 6.  Chronic liver inflammation: clinical implications beyond alcoholic liver disease.

Authors:  Byoung-Jin Park; Yong-Jae Lee; Hye-Ree Lee
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 7.  Osteoporosis and bone fractures in alcoholic liver disease: a meta-analysis.

Authors:  Chang Seok Bang; In Soo Shin; Sung Wha Lee; Jin Bong Kim; Gwang Ho Baik; Ki Tae Suk; Jai Hoon Yoon; Yeon Soo Kim; Dong Joon Kim
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

8.  MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease.

Authors:  Rebecca Mitchell; Jill McDermid; Mang M Ma; Constance L Chik
Journal:  World J Hepatol       Date:  2011-06-27

Review 9.  Classical and emerging roles of vitamin D in hepatitis C virus infection.

Authors:  Julio A Gutierrez; Neil Parikh; Andrea D Branch
Journal:  Semin Liver Dis       Date:  2011-12-21       Impact factor: 6.115

Review 10.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.